Literature DB >> 27913042

Objective analysis of cancer stem cell marker expression using immunohistochemistry.

T J Miller1, M J McCoy2, C Hemmings3, M K Bulsara4, B Iacopetta5, C F Platell6.   

Abstract

Analysis of immunohistochemical expression is often a subjective and semiquantitative process that can lead to the inconsistent reporting of results. To assess the effect that region selection and quantification method have on results, five different cancer stem cell markers were used in this study to compare tissue scoring with digital analysis methods that used three different tissue annotation methods. Samples of tumour and normal mucosa were used from 10 consecutive stage II colon cancer patients and stained for the putative cancer stem cell markers ALDH1, CD44v6, CD133, Lgr5 and SOX2. Tissue scoring was found to have considerably different results to digital analysis with the three different digital methods harbouring concordant results overall. However, SOX2 on normal tissue and CD133 on tumour and normal tissue produced discordant results which could be attributed to the different regions of tissue that were analysed. It is important that quantification method and selection of analysis areas are considered as part of study design to ensure that reproducible and consistent results are reported in the literature.
Copyright © 2016 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ALDH1; CD133; CD44v6; Colorectal cancer; Lgr5; SOX2; cancer stem cell; immunohistochemistry

Mesh:

Substances:

Year:  2016        PMID: 27913042     DOI: 10.1016/j.pathol.2016.09.063

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  7 in total

Review 1.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

2.  Current Pathologic Scoring Systems for Metal-on-metal THA Revisions are not Reproducible.

Authors:  Christiaan Smeekes; Arjen H G Cleven; Bart C H van der Wal; Stefan V Dubois; Remigio W Rouse; Bastiaan F Ongkiehong; Ron Wolterbeek; Rob G H H Nelissen
Journal:  Clin Orthop Relat Res       Date:  2017-07-07       Impact factor: 4.176

3.  Expression of PD-L1 and SOX2 during rectal tumourigenesis: Potential mechanisms for immune escape and tumour cell invasion.

Authors:  Tim J Miller; Melanie J Mccoy; Christine Hemmings; Barry Iacopetta; Cameron F Platell
Journal:  Oncol Lett       Date:  2018-08-21       Impact factor: 2.967

4.  Single-cell heterogeneity in ductal carcinoma in situ of breast.

Authors:  Michael J Gerdes; Yesim Gökmen-Polar; Yunxia Sui; Alberto Santamaria Pang; Nicole LaPlante; Adrian L Harris; Puay-Hoon Tan; Fiona Ginty; Sunil S Badve
Journal:  Mod Pathol       Date:  2017-11-17       Impact factor: 7.842

5.  LGR5 expression predicts peritoneal recurrence after curative resection of primary colon cancer.

Authors:  Hiroshi Nagata; Soichiro Ishihara; Hiroyuki Abe; Tetsuo Ushiku; Junko Kishikawa; Toshiaki Tanaka; Keisuke Hata; Kazushige Kawai; Masashi Fukayama; Hiroaki Nozawa
Journal:  Br J Cancer       Date:  2019-04-19       Impact factor: 7.640

6.  Clinicopathologic and prognostic significance of LGR5, a cancer stem cell marker in patients with colorectal cancer.

Authors:  Chukwuemeka Ihemelandu; Aisha Naeem; Erika Parasido; Deborah Berry; Krysta Chaldekas; Brent T Harris; Olga Rodriguez; Christopher Albanese
Journal:  Colorectal Cancer       Date:  2019-11-12

Review 7.  Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell.

Authors:  Jian-Peng Gao; Wei Xu; Wen-Tao Liu; Min Yan; Zheng-Gang Zhu
Journal:  World J Gastroenterol       Date:  2018-06-28       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.